Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May 15;25(8):563-7.
doi: 10.1016/s0212-6567(00)78569-6.

[Prevalence of Helicobacter pylori infection in primary health care]

[Article in Spanish]
Affiliations

[Prevalence of Helicobacter pylori infection in primary health care]

[Article in Spanish]
A Ràfols Crestani et al. Aten Primaria. .

Abstract

Objectives: To find the prevalence of Helicobacter pylori (Hp) infection in the population as a whole. To assess its relationship with the associated factors described in other studies.

Design: Transversal study of an urban population of 20,000.

Participants: Between 14 and 80 years old. Randomised sampling of the computerised records (640 clinical histories). Necessary sample n = 384 (alpha = 0.05, prior prevalence = 50%, precision 0.05).

Measurements: Breath test with urea marked (13C), age, sex, alcohol and tobacco consumption, social class and dyspepsia and/or gastro-duodenal pathology.

Results: 123 exclusions. 122 losses (23%). 397 people screened, 43.6% male. Average age: 42.6. 41.6% consumed alcohol. 30.5% smoked. Prevalence of dyspepsia, gastritis, gastric ulcer and duodenal ulcer, 14%, 2.8%, 2.8% and 2.0%, respectively. Hp prevalence: 56.1% (95% CI, 51.2-60.1). There were no significant differences between prevalence of Hp+ and sex, dyspepsia, peptic ulcer history, gastritis, alcohol consumption and tobacco consumption. Greatest prevalence of Hp+ in over-70s (73%). Significant linear tendency between presence of Hp+ and age (p < 0.05) and low social class (p < 0.05). The logistic regression analysis found a statistically significant relationship only between the presence of H. pylori and age and social class.

Conclusions: Prevalence was similar to that in other studies. The relationship between low social class and age and greater Hp prevalence was confirmed. Dyspepsia is not a justification for empirical treatment of Hp. Patients with and without the infection must be followed to evaluate morbidity longitudinally.

Objetivos: Conocer la prevalencia de infección por Helicobacter pylori (Hp) en población general. Valorar la relación con los factores asociados descritos en otros ámbitos.

Diseño y ámbito: Estudio transversal. Población urbana: 20.000 personas.

Sujetos: Edad de 14-80 años. Muestreo aleatorio del registro informatizado (640 historias clínicas). Muestra necesaria, 384 (alfa, 0,05; prevalencia previa, 50%; precisión, 0,05).

Mediciones: Prueba del aliento con urea marcada (13C), edad, sexo, consumo de alcohol y tabaco, clase social y dispepsia y/o patología gastroduodenal.

Resultados: Exclusiones, 123; pérdidas, 122 (23%); cribados, 397; varones, 43,6%; edad media, 42,6 años; consumía alcohol, 41,6%; fumaba, 30,5%. Prevalencia de dispepsia, gastritis, ulcus gástrico y duodenal, respectivamente, 14, 2,8, 2,8 y 2,0%. Prevalencia Hp, 56,1% (IC del 95%, 51,2-60,1). No hay diferencias significativas entre prevalencia de Hp+ y sexo, dispepsia, antecedentes de ulcus péptico, gastritis, consumo de alcohol y consumo de tabaco. Máxima prevalencia de Hp+ en mayores de 70 años (73%). Tendencia lineal significativa entre presencia de Hp+ y edad (p < 0,05) y clase social baja (p < 0,05). El análisis de regresión logística sólo encuentra relación estadísticamente significativa entre presencia de Hp y edad y clase social.

Conclusiones: La prevalencia es similar a la de otros estudios. Se confirma la relación entre clase social baja y edad y mayor prevalencia de Hp. La dispepsia no justificaría el tratamiento empírico de Hp. Es necesario el seguimiento de los pacientes con y sin infección para evaluar la morbilidad longitudinalmente.

PubMed Disclaimer

References

    1. Gasbarrani G., Pretolani S., Gatto M.R.A., Tonelli E., Mégraud F., Mayo K. A population based study of HeIicobacter pylori infection in a European country: The San Marino Study. Relations with gastrointestinal diseases. Gut. 1995;36:838–844. - PMC - PubMed
    1. Rosenstock S., Kay L., Rosenstock C., Andersen L.P., Bonnevie O., Jorgensen T. Relation between Helicobacter pylori and gastrointestinal symptoms and syndromes. Gut. 1997;41(2):169–176. - PMC - PubMed
    1. Ausina V. Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer. Med Clin (Barc) 1995;105(15):576–579. - PubMed
    1. Baena Díez J.M., Perpiñán A Sancho, López MompóC C., Rams Rams F., Jiménez Navarrete S., Comet Jaumet D. Tratamiento con omeprazol, claritromicina y amoxicilina durante una semana. Efectividad y tolerancia en la erradicación de Helicobacter pylori en atención primaria. Aten Primaria. 1998;22:547–551. - PubMed
    1. Blecker U., Lanciers S., Hauser B., Vandenplas Y. The prevalence of Helicobacter pylori positivity in a symptom-free population, aged 1 to 40 years. J. Clin. Epidemiol. 1994;47(10):1095–1098. - PubMed